Home Blog Page 998

Milano Cortina 2026 Licensed Candies Released Globally

Developed by Amos Sweets, the collection brings together playful designs, innovative textures, and interactive candy experiences inspired by the Olympic Winter Games Milano Cortina 2026.

MILAN, Feb. 14, 2026 /PRNewswire/ — The Milano Cortina 2026 licensed candy collection, developed by Amos Sweets under licence from the International Olympic Committee, has been released to bring playful and innovative treats to fans and candy lovers. Created specifically for the occasion, the collection features fun designs, unique textures, and interactive experiences that add a touch of sweetness in the celebration of the Winter Olympics.

AMOS Milan-Cortina 2026 Licensed Product Collection KV
AMOS Milan-Cortina 2026 Licensed Product Collection KV

 

AMOS Milan-Cortina 2026 (Paralympic) Licensed Product Collection KV
AMOS Milan-Cortina 2026 (Paralympic) Licensed Product Collection KV

The collection includes the following creative candies:

4D Mascot Gummies – Featuring three-dimensional shapes of the official Olympic and Paralympic mascots, offering a fun and collectible treat experience.

4D Gummy Mascot & Toy Box – Combining 4D mascot gummies with exclusive mascot figurines for an interactive unboxing delight.

TastySounds Music Lollipops – Integrating bone-conduction audio technology with candy, these lollipops play the official Milano Cortina 2026 song Fino all’alba (Until the Dawn) and create a new multi-sensory way to enjoy sweets.

Peelerz Mango Gummies – A peelable mango-shaped gummy with a soft inner center, encouraging playful sharing and exploration — echoing the Olympic spirit of discovery and connection.

Under the IOC licence, the Milano Cortina 2026 candy collection will be available across key global markets, including the European Union, the United Kingdom, the United States, Canada, China, Japan, and South Korea. Distribution in each market complies with the applicable local licensing scope and regulatory requirements.

Available through selected offline and online channels, the collection invites fans and candy lovers alike to celebrate the Olympic spirit through playful, interactive treats that add a touch of sweetness to every moment of the Olympic Winter Games.

ABOUT AMOS FOOD GROUP

Founded in 2004, Amos Food Group is a global confectionery enterprise integrating manufacturing, research and development, and brand management. Guided by its mission to be “the sweet messenger to the world,” the Group delivers joyful and imaginative candy experiences to consumers in more than 75 countries and regions worldwide.

Ranked No. 66 in the 2025 Global Top 100 Candy Companies by Candy Industry, Amos has received international recognition, including the Most Innovative New Products Awards from the National Confectioners Association (USA) and the Superior Taste Awards from the International Taste Institute.

Its flagship brand Amos represents Happiness, known for viral innovations such as Peelerz peelable gummies, 4D Gummies, and TastySounds™ music lollipops. Its nutraceutical gummy brand Biobor represents Health, offering functional gummies formulated with carefully selected nutrients. Through continuous innovation and global partnerships, Amos Food Group brings creativity, joy, and meaningful sweet moments to consumers worldwide.

About the IOC Global Licensing Programme

The licensing agreement between the IOC and Amos Food is the result of the IOC’s Global Licensing Strategy that aims to engage and connect fans through official licensed products that strengthens and promotes the Olympic brand, not only during the Olympic Games, but between Games editions as well.

Alongside the Olympic and Paralympic Games Collections, which celebrate each upcoming edition of the Games, and include a wide range of accessories, souvenirs, fan gear and apparel, the IOC’s core licensing programmes include the Olympic Heritage Collection, which offers products featuring art and design elements from previous Games, and the Olympic Collection, which seeks to engage a young and active audience through unique branded products such as apparel, toys and games, bags, stationery items and sports equipment.

Through the sale of official licensed products, collectables and souvenirs, the Olympic licensing programmes provide fans with a tangible connection to the Olympic Games and the Olympic values. Olympic merchandising items are available for sale at the Olympic Shop.

HTX and AINFT Collaborate to Build New Web3 AI Gateway, Offering Free Access to Leading AI Models and 40,000 USDT Prize Pool

PANAMA CITY, Feb. 14, 2026 /PRNewswire/ — As global artificial intelligence capabilities continue to advance and Web3 infrastructure matures, AI and the crypto ecosystems are entering a new phase of seamless integration. HTX has recently collaborated with AINFT to co-hosted a special AI Challenge campaign featuring a combined prize pool of 40,000 USDT. This innovative event invites users worldwide to experience a new generation of Web3-native AI access.

AINFT: Web3 Gateway to AI

AINFT positions itself as a Web3-native AI gateway designed to provide permissionless, seamless access to leading large language models (LLMs). Users can log in instantly by signing via a TronLink wallet, eliminating the need for email registration or KYC verification and enabling direct on-chain identity authentication. The platform integrates top-tier AI models including Claude Opus 4.5, ChatGPT-5.2, and Gemini 3 Pro, offering unified access for dialogue, reasoning, and content creation across multiple scenarios.

To lower entry barriers, AINFT provides each new user with a one-time allocation of one million free points, allowing immediate access to premium AI models without upfront payment. Once the free quota is exhausted, users can top up on demand using USDT, USDD, USD1, TRX, or NFTs on the TRON network. The platform’s official TRC20 token, $NFT, offers an additional 20% bonus in points when used for payment, supporting a flexible pay-as-you-go model with no subscription requirements.

40,000 USDT Prize Pool: Multiple Rewards in the Second Season

The campaign runs through March 13 at 08:00 (UTC). Following strong engagement in the first phase, Season 2 was launched with an initial 4,000 USDT prize pool unlocked. The overall campaign prize pool totals 40,000 USDT. To participate, users must log in to AINFT’s official website, connect their TronLink wallet, submit their HTX UID and wallet address through the designated form, and complete both the AI challenge tasks on AINFT and the trading tasks on HTX. 

AINFT AI Challenge Offers 13,000 USDT Prize Pool

Users who log in to AINFT and participate in the challenge can compete for three separate prize pools.

  1. Boosted Gift Package: Unlocks progressively based on the number of valid connected wallets within the community. For Season Two, if the valid address count reaches 5,000, the rewards of up to 7,000 USDT will be activated.
  2. Early Bird Gift Package: Rewards the first 500 users each season who connect via TronLink and claim their initial points. 25 users will be selected per season to receive 20 USDT each.
  3. Deposit Gift Package: Users who complete a deposit of any amount during the period will automatically enter a lucky draw. Twenty winners will be selected to share 500 USDT.

Exclusive Triple Rewards for HTX Users: Share 27,000 USDT

Users who complete the registration form and submit their HTX UID and TronLink wallet address can unlock three exclusive incentives:

  • Point Bonus: 1 million points will be awarded to HTX users who access AINFT through the designated link and connect a TronLink wallet. [Join now >>]
  • Welcome Bonus: A 20 USDT bonus is available for users who join AINFT events and sign up for an HTX account during the campaign. Limited to the first 950 registered users.
  • Trading Reward: Users who complete HTX trading tasks—at least 100 USDT in spot volume or 500 USDT in futures volume—will receive a 40 USDT airdrop. Limited to the first 200 qualified users.

Ecosystem Synergy: Practical Case of AI and Crypto

As a global exchange that has long focused on AI-related sectors and innovative asset discovery, HTX continues to support high-quality AI projects and promote collaboration across technology, traffic, and users. As AI computing demand increases and crypto payment systems mature, decentralized AI portals are expected to become cornerstones of next-generation Web3 infrastructure.

The collaboration between HTX and AINFT represents a forward-looking position within this trend. Looking ahead, HTX will continue working with high-quality ecosystem partners to build a more open, efficient, and sustainable Web3 innovation network, providing global users with forward-looking digital asset opportunities and application experiences.

About HTX

Founded in 2013, HTX (formerly Huobi) has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit https://www.htx.com/ or HTX Square , and follow HTX on X, Telegram, and Discord.

Shining in Hong Kong: HTX Ventures and HTX DAO Attend Consensus 2026, Advancing a Sustainable Web3 Ecosystem

PANAMA CITY, Feb. 14, 2026 /PRNewswire/ — Consensus Hong Kong 2026 was successfully held from February 11-12, bringing together global blockchain leaders, developers, and institutional investors. As key industry participants, HTX Ventures and HTX DAO took part in the main conference and a series of high-level satellite events, presenting their long-term strategic roadmap for propelling technical innovation and ecosystem development.


HTX Ventures at Consensus 2026: Justin Sun Delivers Keynote Speech

During the conference, HTX Ventures highlighted its continued focus on early-stage innovation, foundational infrastructure, and global ecosystem synergy. With increasingly defined global regulatory frameworks and maturing digital asset infrastructure, the platform emphasized forward-looking investments across AI, Web3, Real-World Assets (RWA), and modular blockchains. HTX Ventures engaged in in-depth exchanges and strategic resource matchmaking with developers, investment institutions, and project teams from around the globe.

HTX Ventures at Consensus Hong Kong 2026
HTX Ventures at Consensus Hong Kong 2026

On February 12, Justin Sun, Founder of TRON and Advisor to HTX, delivered a keynote speech at the main forum titled “Building Resilient Blockchain Infrastructure for a World in Constant Change.”

Justin Sun keynotes at the main forum.
Justin Sun keynotes at the main forum.

HTX DAO at GWDC 2026: Deepening Engagement in the Developer Ecosystem

Ahead of Consensus, HTX DAO appeared as a Gold Sponsor at Global Web3 Dev Con 2026 (GWDC 2026), held February 8-9 at Hong Kong Cyberport.

At the conference, HTX DAO Ambassador Molly delivered a speech titled “The DAO Path: Decentralization Without Dogma.” Her speech provided a candid reflection on HTX DAO’s evolution and practices on the concept of “The People’s Exchange.”

Molly shared that in its early stages, the team explored radical decentralization models, including proposals to burn 99% of the token supply through community voting. While such experiments embodied strong democratic ideals, they also revealed structural vulnerabilities: emotional, short-term decision-making could undermine long-term ecosystem stability. Over time, the community reached a shared understanding: neither hype-driven proposals nor radical operations bolster token price in the long run. Instead, value is anchored in sound tokenomics, sustainable real-world utility, and a steadfast foundation of long-term holders.

Consequently, over the past two years, HTX DAO has shifted toward a more balanced governance architecture built on three pillars:

  • Optimized Tokenomics: A transparent deflation mechanism to strengthen market trust. This includes allocating 50% of HTX’s quarterly revenue to $HTX token burns—a commitment formally integrated into the whitepaper with regular disclosure of revenue and burn data.
  • Pragmatic On-chain Governance: The DAO preserves community participation while avoiding “performative decentralization” detached from operational sustainability.
  • A Culture of Longtermism: The platform embeds real economic incentives into governance design, ensuring holders benefit from asset growth and risk mitigation.

According to the official data, HTX DAO’s token holder addresses have expanded from approximately 40,000 in its early phase to over 800,000 today. Amid significant market volatility, $HTX has demonstrated relative stability, an outcome the team attributes to its structured tokenomics. At the same time, the team hosted dozens of global offline meetups, spanning various countries and regions to foster direct engagement with their community. This effort has been instrumental in transforming the DAO vision into a tangible reality for users worldwide.

Molly also outlined the DAO’s three major initiatives for 2026:

  • Opening on-chain product interfaces to global developers to foster co-creation and innovation
  • Launching dedicated support programs for emerging narratives such as RWA
  • Expanding volunteer and ambassador systems to cultivate a diverse DAO culture and advance governance

Molly keynotes at GWDC 2026.
Molly keynotes at GWDC 2026.

Expanding the Global Web3 Footprint Through Strategic Engagement

Beyond the developer summit, HTX Ventures and HTX DAO participated in multiple high-profile side events in Hong Kong to boost their global influence.

On February 9, representatives of both platforms attended the “Alpha Night,” hosted by MyToken. During this gathering, which brought together top-tier alpha hunters and institutional investors, the HTX Ventures team established deep connections with numerous high-potential projects, demonstrating their keen insight in identifying premium early-stage assets.

The following day, February 10, HTX DAO appeared as a brand-certified partner at the “Build and Scale in 2026” forum, co-hosted by ChainCatcher, RootData, and Alibaba Cloud.

Throughout this visit to Hong Kong, HTX Ventures and HTX DAO demonstrated their comprehensive penetration into the Web3 space. Moving forward, both platforms will remain committed to the vision of “Building a Metaverse Free Port.” Through continuous ecological investment and collaborative industry development, they aim to lead the industry through market cycles and usher in the next golden era of the crypto world.

About HTX Ventures

HTX Ventures is the global investment arm of HTX, integrating investment, incubation, and research to identify and discover the best and most innovative projects in the market. Visit us here.

 

Login Now & Claim Rewards! HTX Unveils 3,000,000 USDT Mega Airdrop

PANAMA CITY, Feb. 14, 2026 /PRNewswire/ — As the Lunar New Year approaches, HTX is proud to announce the launch of its flagship festive event: the Mega Spring Festival Airdrops. To usher in the Year of the Horse with prosperity and fortune, HTX has committed a massive 3,000,000 USDT prize pool for its global community. Running from February 15, 03:00 (UTC) to March 3, 03:00 (UTC), this comprehensive campaign marks the year’s first major digital asset celebration, featuring daily login rewards, community engagement challenges, “trade & draw” mechanics, and social sharing incentives.


Log in to Claim Your Share of 2,600,000 USDT in Airdrops

During the event, users can claim daily airdrops simply by logging into the HTX App at 03:00 (UTC) and visiting any Spot, Margin, or Futures trading page. Each airdrop contains a randomized selection of rewards, including popular cryptocurrencies, Trading Fee Rebate Vouchers, Futures Trial Bonuses, 0% Margin Interest Vouchers, and APY Booster Coupons. Individual participants can win up to 2,026 USDT!

By removing entry barriers and offering diverse rewards, HTX strives to deliver a seamless “Instant Login Rewards” experience, ensuring that every member of our global community can enjoy effortless participation and immediate rewards.

HTX Community Interaction: 300,000 USDT Giveaway Frenzy

The campaign also introduces the “Ride the Golden Trend” feature, allowing users to earn airdrops directly through the app homepage and comment sections. By exploring the K-line comment sections for designated tokens, users can claim valuable surprise gifts daily at 03:00 (UTC).

HTX has partnered with seven distinguished Diamond Partners—SUN, JST, NFT, BTT, WIN, TRX, and STEEM—to present an exclusive, cross-project “Surprise Gifts” mega drop. Users who engage with the K-line comments for these seven tokens will have the opportunity to claim exclusive rewards on a first-come, first-served basis. Additionally, those who comment daily on relevant posts within the HTX community section will unlock a special, large-scale airdrop during the Lantern Festival.

Complete Tasks for a Chance to Win Big in the 50,000 USDT Lucky Draw

HTX is boosting the festive spirit with a high-stakes lucky draw. By completing simple trades or interactive tasks, users can compete for a 50,000 USDT total prize pool, with a grand prize of 18,888 USDT.

  • Boost Your Odds: Trading designated tokens (SUN, JST, NFT, BTT, WIN, TRX, and STEEM) in Spot or Futures markets will count for triple (3x) the trading volume toward task calculations, significantly increasing your chances of winning.

Visit the event page>>

Send Crypto Gifts to Friends and Share 50,000 USDT

The Lunar New Year is a season for sharing. During this event, users whosend an HTX Crypto Gift of 10 USDT or more to friends will earn a cash reward of up to 20 USDT once the gift is claimed.  This 50,000 USDT prize pool is available on a first-come, first-served basis. This “Share Crypto Gifts & Get Reimbursed” model is designed to foster a cycle of prosperity and luck among friends and family. 

Send Crypto Gifts>>

Compliance, Transparency, and Fairness

To ensure a level playing field, HTX is dedicated to maintaining the highest standards of transparency and equity. The platform strictly monitors for irregular activities to ensure a secure environment.

  • Limit: Each device is limited to one airdrop claim per day.
  • Distribution: All rewards will be credited to the winner’s “My Rewards” section or “Assets” in accordance with the event rules.

HTX remains committed to its user-centric philosophy, continuously expanding its asset ecosystem and creative reward systems. This Mega Spring Festival Airdrop is a sincere expression of gratitude for the continued loyalty of our users. As we embark on a new journey of wealth in the 2026 Year of the Horse, HTX ensures that every login is a step toward a prosperous future.

The luck begins here—let the rewards keep rolling in!

About HTX

Founded in 2013, HTX (formerly Huobi) has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit https://www.htx.com/ or HTX Square , and follow HTX on X, Telegram, and Discord

 

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

SUZHOU, China, Feb. 14, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005) of the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, for the treatment of HER2-positive advanced colorectal cancer (CRC). JSKN003 is independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK).

Colorectal cancer is among the most common malignancies worldwide. China has a high incidence of CRC, with over 500,000 new cases diagnosed annually. Approximately 83% of patients are initially diagnosed at an advanced stage, and about 44% already have distant metastases to organs such as the liver or lungs. Despite advances in systemic therapies, the 5-year survival rate for patients with metastatic CRC remains below 20%, indicating a poor prognosis. There are currently no HER2-targeted therapies approved in China for CRC. For patients with HER2-positive advanced CRC who have failed prior treatments with oxaliplatin, fluorouracil and irinotecan, the median progression-free survival (mPFS) of approved therapies is only 2.0 to 3.7 months, and the median overall survival (mOS) is approximately 7 to 10 months. There remains a significant unmet clinical need within this patient population. Early clinical data of JSKN003 are promising, and JSKN003 has been granted Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for this indication. According to the data presented at the 2025 European Society for Medical Oncology (ESMO) Congress, JSKN003 demonstrated an objective response rate (ORR) of 68.8% and a mPFS of 11.04 months in 32 patients with HER2-positive advanced colorectal cancer, showing a clear therapeutic advantage over existing therapies.

JSKN003-005 is a randomized, open-label, controlled, multicenter Phase III clinical study designed to evaluate the efficacy and safety of JSKN003 versus investigator’s choice of regimen (regorafenib/fruquintinib/trifluridine tipiracil) in HER2-positive advanced CRC patients who have failed prior oxaliplatin, fluorouracil, and irinotecan therapy. The primary endpoint is PFS assessed by blinded independent central review (BICR) according to RECIST v1.1. Secondary endpoints include OS, as well as investigator-assessed PFS and ORR, disease control rate (DCR), duration of response (DOR), time to response (TTR), and other endpoints evaluated by BICR/investigator according to RECIST v1.1. The rapid progression of this study marks a critical stage in the development of JSKN003 for colorectal cancer, and is expected to provide patients with a new therapeutic option.

About JSKN003

JSKN003 is developed by site-specific conjugation to the Fc glycans of anbenitamab, resulting in a homogeneous and stable ADC with a DAR of 4. JSKN003 binds to two HER2 epitopes on tumor cells and release topoisomerase I inhibitors through cellular endocytosis, exerting anti-tumor effects.

Compared to similar ADCs, JSKN003 demonstrates better serum stability, reduced hematological toxicity, and stronger tumor inhibition and bystander effect, resulting in significantly wider therapeutic window.

Multiple registrational studies of JSKN003 are ongoing, including trials in HER2-positive breast cancer (BC), all-comer platinum-resistant ovarian cancer (PROC), HER2-low BC, and HER2-positive colorectal cancer (CRC).

JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for gastric cancer (GC) and gastroesophageal junction cancer (GEJ), has been granted Fast Track Designation (FTD) by the FDA for the treatment of advanced or metastatic platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (PROC), not restricted by HER2 expression, has been granted Breakthrough Therapy Designation (BTD) by the FDA for the treatment of patients with HER2-expressing PROC who have received prior treatment with bevacizumab. It has also been granted two BTDs by the National Medical Products Administration (NMPA) for PROC and HER2-positive advanced CRC that has failed prior oxaliplatin, fluorouracil, and irinotecan therapy.

In September 2024, the Company entered a licensing agreement with JMT-Bio Technology Co., Ltd. (“JMT-Bio”), a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (“CSPC”) (stock code: 1093.HK). JMT-Bio was granted the exclusive license and sublicense rights to develop, sell, offer for sale and commercialize JSKN003, for tumor-related indications in mainland China (excluding Hong Kong, Macau or Taiwan). Alphamab retains exclusive production rights for JSKN003.

About Alphamab Oncology

Alphamab Oncology (Stock Code: 9966.HK) is an innovative biopharmaceutical company focused on oncology. Leveraging proprietary platforms-including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payloads, dual-payload ADCs, and high-concentration subcutaneous formulations, the Company has built a differentiated and globally competitive pipeline, covering cutting-edge candidates in ADCs, bispecific antibodies, and single-domain antibodies.

One product has received market approval: Envafolimab (KN035, brand name: 恩维达®), the world’s first subcutaneously injected PD-(L)1 inhibitor, offering greater convenience and accessibility in cancer treatment. The NMPA has accepted the new drug application for KN026 (Anbenitamab Injection), a HER2 bispecific antibody, for second-line or later HER2-positive gastric cancer. Four bispecific ADC candidates have entered clinical stages, and next-generation ADC pipelines—such as dual-payload ADCs—are advancing rapidly. The Company has established strategic partnerships with organizations including CSPC, ArriVent, and Glenmark, covering both product development and technology platforms.

Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide.

Visa-Free Policies Fuel New Trend in Medical Tourism: International Patients Praise Parkway in Shanghai

SHANGHAI, Feb. 14, 2026 /PRNewswire/ — With the implementation of 144-hour visa-free transit across multiple cities in China, international visitors now enjoy significantly greater convenience. Recently, an intriguing trend has emerged: many foreign nationals arriving in Shanghai for business or tourism are now incorporating “health management” or “convenient medical access” into their packed itineraries, blurring the lines between “leisure travel to China” and “medical travel in China”. Parkway MediCentre Xintiandi, located in the heart of downtown Shanghai, and Parkway Shanghai Hospital, situated near the Hongqiao transportation hub, are increasingly favored by international patients for their high-quality, internationally aligned healthcare services, strategic locations, and seamless communication.

Having been rooted in Shanghai for over two decades, Parkway has witnessed and contributed to the “golden era” of the city’s—and the nation’s—opening-up. To date, Parkway has served nearly 500,000 patients from 77 countries and regions, and has been designated as an official medical examination provider for several embassies, including those of the United Kingdom, Canada, and New Zealand. This extensive international service experience and brand trust position Parkway as a key bridge connecting global health needs with Shanghai’s premium healthcare resources.

As one of the first international high-quality healthcare providers to enter China, Parkway continues to optimize its service network in Shanghai. Through a three-tiered service system—integrating a comprehensive hospital, medical centers, and community clinics across Huangpu, Changning, Minhang, and Pudong—Parkway ensures citywide coverage and efficient linkage with the Yangtze River Delta healthcare ecosystem, continuously enhancing the accessibility and coordination of regional medical services.

As a comprehensive medical institution, Parkway Shanghai Hospital derives its core strength from a highly experienced medical team, complemented by its proximity to Hongqiao International Airport. The hospital offers multidisciplinary outpatient services staffed by full-time seasoned physicians and also leverages an extensive network of high-quality medical resources, including collaborations with nearly 300 clinically experienced experts from Shanghai’s Class A Tertiary hospitals. Through a streamlined appointment system, patients can efficiently access the specialists they need, completing the entire process—from consultation and diagnosis to treatment planning—in a comfortable environment, effectively eliminating long waiting times. Whether for joint replacement, gallbladder surgery, or thyroid cancer surgery—common or complex procedures—patients receive professional, seamless, and high-quality care.

Besides, Parkway MediCentre Xintiandi, Parkway Medical Clinic Gubei, and Parkway Medical & Dental Clinic Biyun cater to medical needs in commercial hubs and tourist-heavy areas. The Parkway MediCentre Xintiandi, spanning nearly 7,000 square meters in the city center, offers fast, precise, and personalized healthcare services tailored to travelers with tight schedules. Two services are particularly noteworthy. To accommodate patients requiring special preparation, the center provides overnight health screening packages, allowing patients to check in the day before their tests to a well-equipped, private observation room. This ensures a comfortable and convenient environment for necessary preoperative or pre-examination preparation. The following morning, patients can efficiently complete their tests, optimizing both time utilization and overall experience. For eligible minor to moderate surgeries, the center has optimized its procedures to enable patients to safely complete admission, surgery, recovery observation, and discharge within 24 hours—saving significant time and offering particular value to business professionals who cannot afford prolonged interruptions to their schedules.

As China continues to deepen its opening-up, Shanghai’s appeal as an international metropolis is increasingly evident in its healthcare sector. With its distinctive brand advantages, strategic locations, and patient-centric service model, Parkway is redefining the “international medical travel” experience, serving as a vital bridge between global healthcare demands and Shanghai’s premier medical resources.

SingHealth Opens Community MRI Centre at Dunearn Village in Collaboration with United Imaging

SINGAPORE, Feb. 14, 2026 /PRNewswire/ — SingHealth, Singapore’s largest public healthcare cluster, has opened a new MRI centre at Dunearn Village, marking its first MRI facility located outside a hospital campus and extending diagnostic imaging services into the community.

Developed in collaboration with United Imaging Healthcare, a global provider of AI-powered medical imaging equipment and healthcare solutions, the centre introduces a new operational model designed to increase imaging capacity while improving patient experience and workflow efficiency.

Fully licensed and operated by RADSC SGH, the facility houses three MRI systems from United Imaging, including two uMR Omega units and one uMR 680. The uMR Omega, United Imaging’s flagship MR platform featuring the world’s first ultra-wide 75 cm bore and advanced AI-enabled imaging technologies, is designed to broaden clinical capability while enhancing patient comfort by reducing anxiety and accommodating a wider range of body types.

The project commenced in April 2025 and was officially opened on 14 February 2026. The centre also marked the signing of the first Reference Site Agreement between SingHealth and United Imaging Healthcare on 21 November 2025.

Located within a community setting, the centre incorporates workflow and design innovations aimed at enhancing both patient and staff experience. These include mobile registration and in-app payment via the Health Buddy application, recyclable patient gowns, private sub-waiting pods, and redesigned patient flow to minimise movement and waiting time. Expanded clinical roles for Patient Support Associates and credentialed nurses further improve operational flexibility and efficiency.

Additional features include a door-frame metallic detector for safer and more ergonomic screening, scan cohorting strategies to optimise utilisation, and a multi-dosing injector system that reduces contrast waste and consumables while supporting sustainability goals.

Professor Andrew Tan, Chairman of Radiological Sciences at SingHealth, noted that:  ‘The new SingHealth MRI Centre reflects our continuous commitment to person-centred care and environmental stewardship. By synergising the advanced capabilities of UIH with SingHealth’s innovative service delivery models, we are elevating the standards for diagnostic imaging and ensuring that they prioritise both the patient experience and the importance of environmental sustainability. With these enhancements, we are excited to bring this key service to more patients and ensure that they continue to receive accessible and the best care possible.”

Jusong Xia, PhD, President of International Business at United Imaging Healthcare, added: “This collaboration reflects a shared commitment to expanding access to advanced medical imaging through intelligent technology. By integrating AI-powered MRI solutions into community-based care settings, we aim to support more efficient clinical workflows while helping make high-quality diagnostic services more accessible to patients across Singapore and the broader Southeast Asia region. This is an important step toward our mission of Equal Healthcare for All.”

By extending MRI services beyond hospital campuses, the SingHealth MRI Centre at Dunearn Village increases system-wide capacity while piloting a scalable approach to community-based diagnostic imaging. The collaboration brings together SingHealth’s clinical expertise and United Imaging’s AI-enabled MRI technology to support more accessible, efficient imaging services for patients in Singapore.

Stablecoin Airdrops and 1,000 USDe Jackpot: Bybit Earn Announces Valentine’s Day Surprises for New Users

DUBAI, UAE, Feb. 14, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has in store Valentine’s specials for new users from now until March 12, 2026, centered around Bybit Earn‘s stablecoin yield products including its flagship Stable Love Trio: BYUSDT, Mantle Vault, and USDe/USDtb.

The month-long affair welcomes all eligible Bybit new users who registered between January 1 to March 31, 2026. Participants stand to win lucky draw tickets to a 1,000 USDe jackpot draw through an initial deposit of $100 in value, successful referrals, and engagement with Earn products including BYUSDT, Mantle Vault staking, and USDe or USDtb spot trading or conversion.

A bonus track is available for on-chain mining fans. Eligible users who commit to minting 5,000 or more USDe or USDtb via On-Chain Earn will receive additional entries and a better chance to win from the jackpot.

The Trio are highlighted this Valentine’s season at a time when both digital assets and traditional financial markets are in flux. Bybit Earn provides an avenue for the prudent trader who are committed to sustainable growth through diversification.

Bybit Earn’s signature stablecoin yield products, with BYUSDT and Mantle Vault exclusive on Bybit, offer investors a way to access predictable yield opportunities while maintaining exposure to dollar-pegged assets. The structured nature of stablecoin earning mechanisms make them particularly relevant for risk-conscious investors seeking to preserve capital while earning passive income.

Registration is required. Rewards are distributed on a first-come, first-served basis. Terms and conditions apply. For details of participation rules, users may visit: Earn Your Stablecoin Valentine: Win a 1000 USDe Airdrop Jackpot

#Bybit / #TheCryptoArk / #IMakeIt

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | YouTube